Phase 2 Study of ADI-PEG 20 Plus Lenvatinib Treatment in Subjects With Unresectable Hepatocellular Carcinoma
Clinical trial NCT06034977 · UNKNOWN
Trial details
- NCT number
- NCT06034977
- Sponsor
- Chang Gung Memorial Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-01
- Primary completion
- 2026-07-23
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.